Mediera Corporation (TPEX:5398)

Taiwan · Delayed Price · Currency is TWD

16.75

-0.30 (-1.76%)

May 29, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Physical Examination	129.88M	134.57M	19.33M	49.47M	-
Physical Examination Growth	-3.48%	596.11%	-60.92%	-	-
Pharmaceutical Biotechnology	99.97M	103.92M	173.56M	208.08M	351.56M
Pharmaceutical Biotechnology Growth	-3.80%	-40.13%	-16.59%	-40.81%	-4.42%
Total	229.85M	238.48M	192.90M	257.55M	351.56M
Total Growth	-3.62%	23.63%	-25.10%	-26.74%	-4.44%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	229.85M	238.48M	192.90M	257.55M	351.56M
Taiwan Growth	-3.62%	23.63%	-25.10%	-26.74%	-4.42%
Total	229.85M	238.48M	192.90M	257.55M	351.56M
Total Growth	-3.62%	23.63%	-25.10%	-26.74%	-4.44%

Source: S&P Global Market Intelligence.